Migraine is characterised by a wide spectrum of clinical symptoms, including severe and persistent headaches often ...

A teacher whose years of continuous headaches were cured after a Botox treatment has presented the nurse that helped her with ...

Shiratronics Inc. raised $66 million in an oversubscribed series B financing round to support completion of its recently ...

Axsome's financials show a market cap of $4.1bn and a cash runway of 4-5 quarters, but risks include potential dilution and FDA approval uncertainty. Learn more on AXSM stock here.

ShiraTronics, a clinical-stage medical device company developing neurostimulation therapies for chronic migraine patients, ...

Explore the impact of severe migraine and discuss the critical need for conversation between health care providers and ...

Ubrogepant use during the migraine prodrome is tied to better ability to function normally and reduced activity limitations.

ShiraTronics announced today that it closed a $66 million Series B financing round to support its Migraine Therapy System.

Major funds have kicked off negotiations with the Health Department, and concede the rise they want creates a “very difficult ...

Luo musician Atommy Sifa appealed for prayers after being admitted to Adiedo Health Centre due to a migraine triggered by the ...